Abound Wealth Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30K | Sell |
77
-7
| -8% | -$2.72K | 0.01% | 274 |
|
2025
Q1 | $36.5K | Sell |
84
-6
| -7% | -$2.61K | 0.01% | 230 |
|
2024
Q4 | $33.1K | Sell |
90
-3
| -3% | -$1.1K | 0.01% | 220 |
|
2024
Q3 | $48.2K | Buy |
93
+7
| +8% | +$3.63K | 0.02% | 181 |
|
2024
Q2 | $46.5K | Sell |
86
-2
| -2% | -$1.08K | 0.02% | 159 |
|
2024
Q1 | $45.5K | Buy |
88
+3
| +4% | +$1.55K | 0.02% | 155 |
|
2023
Q4 | $40.3K | Sell |
85
-23
| -21% | -$10.9K | 0.02% | 171 |
|
2023
Q3 | $47K | Buy |
108
+5
| +5% | +$2.18K | 0.02% | 140 |
|
2023
Q2 | $45.8K | Buy |
103
+12
| +13% | +$5.33K | 0.02% | 142 |
|
2023
Q1 | $41.8K | Buy |
91
+22
| +32% | +$10.1K | 0.02% | 141 |
|
2022
Q4 | $35.4K | Sell |
69
-11
| -14% | -$5.64K | 0.02% | 144 |
|
2022
Q3 | $36.4K | Buy |
+80
| New | +$36.4K | 0.02% | 141 |
|